Regenerative Medical Technology Group Inc. (RMTG) stock
RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
$0.04−0.00 (-5.76%)
Close on Oct 19, 2026Market cap $497.25KP/E –Yield –
Regenerative Medical Technology profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Regenerative Medical Technology's profit margin for the twelve months ending Jun 30, 2026 was -101.2%. For fiscal 2025 it was -153.2%, against -135.4% the year before. The highest annual figure on record is -135.4% in fiscal 2024.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -153.2% | −17.7 |
| FY2024 | Dec 31, 2024 | -135.4% | +271.8 |
| FY2023 | Dec 31, 2023 | -407.2% | −47.3 |
| FY2022 | Dec 31, 2022 | -359.9% | +2582.6 |
| FY2021 | Dec 31, 2021 | -2942.4% | +7761.0 |
| FY2020 | Dec 31, 2020 | -10703.5% | −2368.3 |
| FY2019 | Dec 31, 2019 | -8335.2% | −4229.6 |
| FY2018 | Dec 31, 2018 | -4105.6% | −2816.3 |
| FY2017 | Dec 31, 2017 | -1289.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -72.2% | +74.6 |
| Q1 FY2026 | Mar 31, 2026 | -33.2% | +22.5 |
| Q4 FY2025 | Dec 31, 2025 | -88.6% | −46.4 |
| Q3 FY2025 | Sep 30, 2025 | -368.8% | −278.8 |
| Q2 FY2025 | Jun 30, 2025 | -146.8% | +115.0 |
| Q1 FY2025 | Mar 31, 2025 | -55.7% | +184.3 |
| Q4 FY2024 | Dec 31, 2024 | -42.2% | −0.6 |
| Q3 FY2024 | Sep 30, 2024 | -89.9% | +815.6 |
| Q2 FY2024 | Jun 30, 2024 | -261.8% | +300.1 |
| Q1 FY2024 | Mar 31, 2024 | -240.0% | −27.6 |
| Q4 FY2023 | Dec 31, 2023 | -41.6% | +133.7 |
| Q3 FY2023 | Sep 30, 2023 | -905.5% | −539.9 |
| Q2 FY2023 | Jun 30, 2023 | -561.8% | −60.0 |
| Q1 FY2023 | Mar 31, 2023 | -212.4% | +348.9 |
| Q4 FY2022 | Dec 31, 2022 | -175.3% | +446.5 |
| Q3 FY2022 | Sep 30, 2022 | -365.6% | +5642.2 |
| Q2 FY2022 | Jun 30, 2022 | -501.8% | +5370.9 |
| Q1 FY2022 | Mar 31, 2022 | -561.3% | +10069.0 |
| Q4 FY2021 | Dec 31, 2021 | -621.7% | −213973.9 |
| Q3 FY2021 | Sep 30, 2021 | -6007.8% | +54323.9 |
| Q2 FY2021 | Jun 30, 2021 | -5872.8% | +5905.2 |
| Q1 FY2021 | Mar 31, 2021 | -10630.4% | −3154.5 |
| Q4 FY2020 | Dec 31, 2020 | 213352.2% | +234964.6 |
| Q3 FY2020 | Sep 30, 2020 | -60331.7% | −32447.7 |
| Q2 FY2020 | Jun 30, 2020 | -11778.0% | −52696.3 |
| Q1 FY2020 | Mar 31, 2020 | -7475.9% | +15040.0 |
| Q4 FY2019 | Dec 31, 2019 | -21612.4% | −10401.1 |
| Q3 FY2019 | Sep 30, 2019 | -27884.0% | −22509.2 |
| Q2 FY2019 | Jun 30, 2019 | 40918.4% | +40534.6 |
| Q1 FY2019 | Mar 31, 2019 | -22515.9% | −21735.2 |
| Q4 FY2018 | Dec 31, 2018 | -11211.3% | – |
| Q3 FY2018 | Sep 30, 2018 | -5374.8% | – |
| Q2 FY2018 | Jun 30, 2018 | 383.8% | – |
| Q1 FY2018 | Mar 31, 2018 | -780.7% | – |
See a number that looks wrong?